At a glance
ClinicalIndex Comparison RecordN/ACompleted· 56 enrolled
Drug / intervention
EUS guided FNA and fine needle punctiondevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prospective Evaluation of the Significance of the Pro-core® Needle in Differential Diagnosis of Tumorous and Inflammatory Processes
In Brief
A clinical study evaluating EUS guided FNA and fine needle punction for Pancreatic Neoplasm. Completed, enrolled 56 participants across 1 site.
Detailed Summary
The study is designed to evaluate the diagnostic accuracy of a new designed endoscopic ultrasonography (EUS) Core biopsy aspiration needle in comparison to a conventional EUS aspiration needle in GI-tumors.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPancreatic Neoplasm
CountriesGermany
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartAug 2011
First PostedJul 2014
Primary CompletionOct 2014
TodayJul 2026
First PostedJul 3, 2014
Enrollment StartAug 1, 2011
Primary CompletionOct 1, 2014
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 12.0 years ago
Interventions
EUS guided FNA and fine needle punctiondevice
punction of a suspect area by a EUS guided fine needle as well as pro core fine needle to evacuate histology and smear biologics